Answers are grounded in this paper and cite their sources.
Painful vertebral metastases are common and disabling, and several antalgic strategies are used (radiotherapy, interventional procedures, drugs and physical rehabilitation) yet their comparative efficacy, and their effect on physical function, has not been synthesised in one appraisal restricted to vertebral disease. We aimed to provide such a synthesis. We conducted a systematic review and meta-analysis of randomised controlled trials of any antalgic therapy in adults with strictly vertebral bone metastases. Four databases were searched to 20 July 2026. Risk of bias was assessed with RoB 2 and certainty with GRADE; quantitative meta-analysis (dichotomous pain response, random-effects risk ratios) was limited to the stereotactic-versus-conventional radiotherapy comparison; all other antalgic comparisons were synthesised narratively. Nineteen trials were included. Stereotactic radiotherapy more than doubled complete pain response at 3 months versus conventional radiotherapy (RR 2.26, 95% CI 1.48–3.44; I²=0%; moderate certainty); its effect on overall response was inconsistent and very uncertain (directionally opposed trials, I²=91%, not pooled), no clear evidence of an increase in vertebral compression fracture was detected (RR 0.84, 0.56–1.26; low certainty), and the 6-month complete-response estimate remained uncertain. Evidence for augmentation, ablation and pharmacological adjuncts was sparse and of low or very-low certainty. Across all 19 trials, efficacy was judged by pain; a dedicated measure of physical function or disability was reported in only three, and was primary in none. Stereotactic radiotherapy deepens the complete pain response at 3 months, whereas a broader benefit was not demonstrated and its durability at 6 months remained uncertain; no clear evidence of increased fracture risk was detected; other antalgic strategies remain weakly evidenced. Within the antalgic trials reviewed, a dedicated measure of physical function was rarely used and never a primary outcome, so function-focused rehabilitation trials are an important research priority.
No takes yet. Share an insight, caveat, or question.
Castro‐Martín et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: